These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 30753112)

  • 1. Amino acid and fatty acid metabolomic profile during fasting and hyperinsulinemia in girls with polycystic ovarian syndrome.
    Cree-Green M; Carreau AM; Rahat H; Garcia-Reyes Y; Bergman BC; Pyle L; Nadeau KJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E707-E718. PubMed ID: 30753112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome.
    Lewy VD; Danadian K; Witchel SF; Arslanian S
    J Pediatr; 2001 Jan; 138(1):38-44. PubMed ID: 11148510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral insulin resistance in obese girls with hyperandrogenism is related to oxidative phosphorylation and elevated serum free fatty acids.
    Cree-Green M; Newcomer BR; Coe G; Newnes L; Baumgartner A; Brown MS; Pyle L; Reusch JE; Nadeau KJ
    Am J Physiol Endocrinol Metab; 2015 May; 308(9):E726-33. PubMed ID: 25714677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining a nontargeted and targeted metabolomics approach to identify metabolic pathways significantly altered in polycystic ovary syndrome.
    Chang AY; Lalia AZ; Jenkins GD; Dutta T; Carter RE; Singh RJ; Nair KS
    Metabolism; 2017 Jun; 71():52-63. PubMed ID: 28521878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?
    Li S; Chu Q; Ma J; Sun Y; Tao T; Huang R; Liao Y; Yue J; Zheng J; Wang L; Xue X; Zhu M; Kang X; Yin H; Liu W
    J Clin Endocrinol Metab; 2017 Mar; 102(3):810-821. PubMed ID: 27886515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS.
    Escobar-Morreale HF; Samino S; Insenser M; Vinaixa M; Luque-Ramírez M; Lasunción MA; Correig X
    Clin Chem; 2012 Jun; 58(6):999-1009. PubMed ID: 22427353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers.
    Patel SS; Truong U; King M; Ferland A; Moreau KL; Dorosz J; Hokanson JE; Wang H; Kinney GL; Maahs DM; Eckel RH; Nadeau KJ; Cree-Green M
    Vasc Med; 2017 Apr; 22(2):85-95. PubMed ID: 28095749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total ghrelin levels during acute insulin infusion in patients with polycystic ovary syndrome.
    Micic D; Sumarac-Dumanovic M; Kendereski A; Cvijovic G; Zoric S; Pejkovic D; Micic J; Milic N; Dieguez C; Casanueva FF
    J Endocrinol Invest; 2007 Nov; 30(10):820-7. PubMed ID: 18075283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
    Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
    Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
    Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skeletal muscle mitochondrial function in polycystic ovarian syndrome.
    Rabøl R; Svendsen PF; Skovbro M; Boushel R; Schjerling P; Nilas L; Madsbad S; Dela F
    Eur J Endocrinol; 2011 Oct; 165(4):631-7. PubMed ID: 21798960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum metabolomics profiling by proton nuclear magnetic resonance spectrometry of the response to single oral macronutrient challenges in women with polycystic ovary syndrome (PCOS) compared with male and female controls.
    Escobar-Morreale HF; Martínez-García MÁ; Insenser M; Cañellas N; Correig X; Luque-Ramírez M
    Biol Sex Differ; 2023 Sep; 14(1):62. PubMed ID: 37736753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic profiling of fatty acid and amino acid metabolism in youth with obesity and type 2 diabetes: evidence for enhanced mitochondrial oxidation.
    Mihalik SJ; Michaliszyn SF; de las Heras J; Bacha F; Lee S; Chace DH; DeJesus VR; Vockley J; Arslanian SA
    Diabetes Care; 2012 Mar; 35(3):605-11. PubMed ID: 22266733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Lipolysis, Diminished Fat Oxidation, and Metabolic Inflexibility in Obese Girls With Polycystic Ovary Syndrome.
    Kim JY; Tfayli H; Michaliszyn SF; Arslanian S
    J Clin Endocrinol Metab; 2018 Feb; 103(2):546-554. PubMed ID: 29220530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-Mediated Substrate Use in Women With Different Phenotypes of PCOS: the Role of Androgens.
    Tosi F; Villani M; Migazzi M; Faccin G; Garofalo S; Fiers T; Kaufman JM; Bonora E; Moghetti P
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3414-e3425. PubMed ID: 34050757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hyperglycemia and hyperinsulinemia on glutathione peroxidase activity in non-obese women with polycystic ovary syndrome.
    Savic-Radojevic A; Bozic Antic I; Coric V; Bjekic-Macut J; Radic T; Zarkovic M; Djukic T; Pljesa-Ercegovac M; Panidis D; Katsikis I; Simic T; Macut D
    Hormones (Athens); 2015; 14(1):101-8. PubMed ID: 25402379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome.
    Tayachew B; Vanden Brink H; Garcia-Reyes Y; Rahat H; D'Alessandro A; Frank DN; Robertson CE; Silveira L; Kelsey M; Pyle L; Cree-Green M
    Front Physiol; 2022; 13():887077. PubMed ID: 35800349
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
    Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.